Þorvarður Jón Löve

5.5k total citations · 1 hit paper
78 papers, 2.6k citations indexed

About

Þorvarður Jón Löve is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Þorvarður Jón Löve has authored 78 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Rheumatology, 33 papers in Immunology and 20 papers in Hematology. Recurrent topics in Þorvarður Jón Löve's work include Spondyloarthritis Studies and Treatments (38 papers), Psoriasis: Treatment and Pathogenesis (31 papers) and Rheumatoid Arthritis Research and Therapies (30 papers). Þorvarður Jón Löve is often cited by papers focused on Spondyloarthritis Studies and Treatments (38 papers), Psoriasis: Treatment and Pathogenesis (31 papers) and Rheumatoid Arthritis Research and Therapies (30 papers). Þorvarður Jón Löve collaborates with scholars based in Iceland, United States and Sweden. Þorvarður Jón Löve's co-authors include Hyon K. Choi, Joel M. Gelfand, Alexis Ogdie, Björn Guðbjörnsson, Yuqing Zhang, Kevin Haynes, Helgi Valdimarsson, Andrea B. Troxel, Elizabeth W. Karlson and Jóhann E. Guðjónsson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Þorvarður Jón Löve

73 papers receiving 2.5k citations

Hit Papers

Risk of major cardiovascular events in patients with psor... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
    2014 354 citations Alexis Ogdie, Yiding Yu et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Þorvarður Jón Löve Iceland 24 1.6k 1.6k 648 372 292 78 2.6k
Majed Khraishi Canada 22 1.2k 0.8× 1.5k 1.0× 725 1.1× 213 0.6× 173 0.6× 65 2.2k
Antonio Carletto Italy 22 620 0.4× 797 0.5× 253 0.4× 200 0.5× 231 0.8× 133 2.0k
C. Gaujoux-Viala France 22 624 0.4× 2.0k 1.3× 748 1.2× 64 0.2× 162 0.6× 87 2.7k
Marie Holmqvist Sweden 25 436 0.3× 1.3k 0.8× 188 0.3× 198 0.5× 822 2.8× 70 2.4k
John Sibley Canada 20 528 0.3× 1.7k 1.1× 357 0.6× 135 0.4× 235 0.8× 37 2.8k
Andrew Koenig United States 26 903 0.6× 2.3k 1.5× 985 1.5× 77 0.2× 194 0.7× 56 2.8k
Beverley Harrison United Kingdom 20 397 0.3× 1.5k 1.0× 479 0.7× 92 0.2× 92 0.3× 29 1.9k
E. J. ter Borg Netherlands 24 651 0.4× 1.6k 1.1× 364 0.6× 48 0.1× 200 0.7× 46 2.2k
C.J. Haagsma Netherlands 20 479 0.3× 2.0k 1.3× 855 1.3× 58 0.2× 120 0.4× 38 2.8k
Grace S. Park United States 19 409 0.3× 860 0.5× 221 0.3× 114 0.3× 91 0.3× 31 1.4k

Countries citing papers authored by Þorvarður Jón Löve

Since Specialization
Citations

This map shows the geographic impact of Þorvarður Jón Löve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Þorvarður Jón Löve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Þorvarður Jón Löve more than expected).

Fields of papers citing papers by Þorvarður Jón Löve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Þorvarður Jón Löve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Þorvarður Jón Löve. The network helps show where Þorvarður Jón Löve may publish in the future.

Co-authorship network of co-authors of Þorvarður Jón Löve

This figure shows the co-authorship network connecting the top 25 collaborators of Þorvarður Jón Löve. A scholar is included among the top collaborators of Þorvarður Jón Löve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Þorvarður Jón Löve. Þorvarður Jón Löve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kristjánsson, Sigurður, Sigurður Ólafsson, Magnús Gottfreðsson, Þorvarður Jón Löve, & Einar S. Björnsson. (2025). Clinically Important Decrease in Liver Stiffness Following Treatment for Hepatitis C: Outcome of the TraP HepC Nationwide Elimination Program. Journal of Clinical Medicine. 14(11). 3982–3982.
2.
3.
Hauksdóttir, Arna, Edda Björk Þórðardóttir, Fenfen Ge, et al.. (2024). Depressive symptom trajectories among general population during the COVID-19 pandemic in Iceland: a prospective cohort study (2020–2023). SHILAP Revista de lepidopterología. 2(2). e001294–e001294.
4.
Glintborg, Bente, Daniela Di Giuseppe, Johan K. Wallman, et al.. (2023). Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries. Annals of the Rheumatic Diseases. 82(6). 820–828. 14 indexed citations
5.
Laheru, Dhruvkumar, Sueli Carneiro, Vito Di Lernia, et al.. (2022). Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of Rheumatology. 50(3). jrheum.220313–jrheum.220313. 8 indexed citations
6.
Cordtz, René, Johan Askling, Bénédicte Delcoigne, et al.. (2022). Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study. RMD Open. 8(2). e002776–e002776. 2 indexed citations
7.
Löve, Þorvarður Jón, et al.. (2022). Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance. Frontiers in Immunology. 13. 876271–876271. 14 indexed citations
8.
Hellgren, Karin, Christine Ballegaard, Bénédicte Delcoigne, et al.. (2020). Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors – a Nordic cohort study. Lara D. Veeken. 60(8). 3656–3668. 9 indexed citations
9.
Dreyer, Lene, Merete Lund Hetland, Bente Glintborg, et al.. (2020). Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study. Lara D. Veeken. 60(1). 140–146. 4 indexed citations
10.
Lindström, Ulf, Bente Glintborg, Daniela Di Giuseppe, et al.. (2020). Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis. Lara D. Veeken. 60(8). 3635–3645. 18 indexed citations
11.
Lindström, Ulf, Bente Glintborg, Daniela Di Giuseppe, et al.. (2020). THU0394 COMPARISON OF TREATMENT RETENTION OF SECUKINUMAB AND TNF-INHIBITORS IN PSORIATIC ARTHRITIS. OBSERVATIONAL DATA FROM A NORDIC COLLABORATION.. Annals of the Rheumatic Diseases. 79. 431–432. 1 indexed citations
12.
Ólafsson, Sigurður, Þórarinn Tyrfingsson, Valgerður Rúnarsdóttir, et al.. (2019). THU-412-Iceland may already have reached the WHO 2030 targets for diagnosis and treatment of hepatitis C virus infection: Results from the treatment as prevention for hepatitis C (Trap HepC) program. Journal of Hepatology. 70(1). e337–e338. 8 indexed citations
13.
Ogdie, Alexis, Daniel B. Shin, Joshua F. Baker, et al.. (2017). The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study. Annals of the Rheumatic Diseases. 76(5). 882–885. 57 indexed citations
14.
Højgaard, Pil, Bente Glintborg, Lars Erik Kristensen, et al.. (2016). The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries. Lara D. Veeken. 55(12). 2191–2199. 107 indexed citations
15.
Lu, Na, et al.. (2016). Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Annals of the Rheumatic Diseases. 76(3). 521–525. 70 indexed citations
16.
Löve, Þorvarður Jón, Abrar A. Qureshi, Elizabeth W. Karlson, Joel M. Gelfand, & Hyon K. Choi. (2015). Prevalence of the Metabolic Syndrome in Psoriasis. 3 indexed citations
17.
Ogdie, Alexis, Yiding Yu, Kevin Haynes, et al.. (2014). Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Annals of the Rheumatic Diseases. 74(2). 326–332. 354 indexed citations breakdown →
18.
Dubreuil, Maureen, Y. H. Rho, Adrian Man, et al.. (2013). Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Lara D. Veeken. 53(2). 346–352. 114 indexed citations
19.
Löve, Þorvarður Jón, Jóhann E. Guðjónsson, Helgi Valdimarsson, & Björn Guðbjörnsson. (2012). Psoriatic Arthritis and Onycholysis — Results from the Cross-sectional Reykjavik Psoriatic Arthritis Study. The Journal of Rheumatology. 39(7). 1441–1444. 30 indexed citations
20.
Löve, Þorvarður Jón, Björn Guðbjörnsson, Jóhann E. Guðjónsson, & Helgi Valdimarsson. (2007). Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course.. PubMed. 34(10). 2082–8. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Majed Khraishi Breakdown of academic impact, for papers by Antonio Carletto Breakdown of academic impact, for papers by C. Gaujoux-Viala Breakdown of academic impact, for papers by Marie Holmqvist Breakdown of academic impact, for papers by John Sibley Breakdown of academic impact, for papers by Andrew Koenig Breakdown of academic impact, for papers by Beverley Harrison Breakdown of academic impact, for papers by E. J. ter Borg Breakdown of academic impact, for papers by C.J. Haagsma Breakdown of academic impact, for papers by Grace S. Park
Rankless by CCL
2026